Business Operations:

Sector: Healthcare
Industry: Healthcare Plans

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Revenue projections:

CVS's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio	0.866000
forwardPE	10.858576
debtToEquity	95.503000
earningsGrowth	1.888000
revenueGrowth	0.071000
grossMargins	0.136450
operatingMargins	0.038610
trailingEps	3.800000
forwardEps	8.535190

CVS Health Corporation's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
CVS's elevated debt-to-equity ratio reflects a high level of debt relative to equity, signaling that the company is heavily leveraged. This reliance on debt could increase financial risk in periods of economic uncertainty.
CVS's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that CVS is likely to outperform its previous year's financial performance.

Price projections:

CVS's current price does not reveal any distinct risks or opportunities compared to its projections. This neutral assessment suggests stability, where investors might choose to retain their current positions until future developments warrant a reassessment.

Insider Transactions:

3 sales of CVS Health Corporation stock were made, with market price at 84.89666748046875 per share.There were no sell transactions recorded during the period under consideration.Investors have been purchasing CVS Health Corporation more than selling it at current price levels, which may reflect optimism. This pattern suggests that the market expects favorable outcomes for the stock, leading to increased buying interest.

Recommendation changes over time:

Analysts have maintained a buy bias for CVS, which could prompt investors to consider the stock as a viable investment. With this positive outlook, CVS is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.